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OBJECTIVE: The aim of the present study was to analyze the effect Cissus quadrangularis plant petroleum ether extract on the 
development of long bones during the intra-uterine developmental stage in rats. 
METHODS: Pregnant rats (n=12) were randomly assigned into either a control group (n=6) or a Cissus quadrangularis treatment 
(n=6) group. Pregnant rats in the Cissus quadrangularis group were treated with Cissus quadrangularis petroleum ether extract at 
a dose of 500 mg/kg body weight from gestation day 9 until delivery. The animals in the control group received an equal volume 
of saline. Newborn pups were collected from both groups for alizarin red S - alcian blue staining to differentiate ossified and unos-
sified cartilage. The ossified cartilage (bone) was morphometrically analyzed using Scion image software. 
RESULTS: Morphometric analysis revealed that the percentage of the total length of ossified cartilage (bone) in pups born to 
treated dams was significantly higher (P<0.001-   0.0001) than that of the control group. 
CONCLUSION: The results of the present study suggest that maternal administration of Cissus quadrangularis petroleum ether 
extract during pregnancy can stimulate the development of fetal bone growth during the intra-uterine developmental period. 
KEYWORDS: Estrogens; Phytoestrogens; Ossification; Alizarin red-Alcian blue. 
INTRODUCTION 
There is increasing evidence that the intra-uterine 
environment influences the risk of developing chronic 
diseases such as cardiovascular disease, diabetes, and 
osteoporosis later in life.1 This is thought to occur through 
fetal programming, which refers to the ability of changes in 
environmental factors (e.g., nutrition, stress, and exposure to 
toxins) at critical periods during development to permanently 
alter the structure, physiology, or metabolism of the body.1 
Exposure to ethanol in utero has a number of effects on 
the developing skeleton, while these effects do not appear 
to normalize after birth.2 Cissus quadrangularis (CQ) is a 
weed plant that is used commonly in India and Sri Lanka to 
hasten the fracture healing process.3-5 Leaf, stem, and root 
extracts from this plant are used in the management of various 
ailments.6-14 Phytochemical analysis of Cissus quadrangularis 
revealed a high content of ascorbic acid, carotene, phytosterol 
substances, and calcium,15 and there are reports of the 
presence of β-sitosterol, δ  -amyrin, and δ-amyrone.16 All of 
these components have potentially different metabolic and 
physiological effects.17-19 Phytoestrogens, which are widely 
present in different plants in our environment, seem to have 816
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actions similar to estrogen on bone cells in vitro.20,21 Estrogen 
receptors have been detected in bone cells, both in osteoblasts 
and osteoclasts,22-24 suggesting the direct action of estrogens 
on these bone cells. Several studies have shown that estrogens 
can modulate bone cell physiology in vitro by a direct estrogen 
receptor-mediated mechanism.25-26 This evidence implicates a 
direct effect of estrogen on the skeleton and alternatively 
on bone tissue turnover. Although several excellent reviews 
have documented the beneficial effects of phytoestrogens on 
humans and laboratory animals,20,21 none have reported on the 
role of phytoestrogens on fetal rat bone ossification. 
In our previous studies, we have demonstrated the effect 
of an ethanol extract of CQ on the ossification of fetal 
long bones and the thicknesses of cortical and trabecular 
bones of neonatal pups treated during days 9 through 21 of 
gestation.18,19 In our quest to identify and isolate the active 
principles of the CQ extract, we have more effectively 
extracted specific chemical compounds from the plant using 
different organic solvents, and have tested these extracts 
for their osteostimulant role in vitro. We have observed 
that CQ petroleum ether extract has a pronounced effect on 
osteoblasts (unpublished data); however, it is still unknown 
whether this CQ petroleum ether extract similarly affects the 
development of bone in utero. Therefore, it is reasonable to 
study the role of this extract, which is believed to extract the 
phytogenic steroids in the plant, on the development of fetal 
bones. Considering the paucity of available data concerning 
the effect of medicinal plants on the ossification of fetal 
bone, we aimed to systematically evaluate the in vivo effect 
of CQ petroleum ether extract on the skeletons of neonatal 
pups treated during the gestation period. 
MATERIALS AND METHODS 
Plant material and extraction 
The stem of Cissus quadrangularis was collected from 
the Nalgonda District of Andhra Pradesh in India, identified, 
and authenticated by a botanist. A voucher specimen was 
deposited in the Pharmacology Department of Manipal 
University. The fleshy stems (2.5 kg) were washed, cut into 
small pieces, air-dried, and crushed into powder. The stem 
powder was exhaustively extracted with 95% ethanol using a 
Soxhlet apparatus, and a extract yield of 225 g was obtained. 
The total ethanol extract was concentrated in a vacuum, 
dissolved in water, and then partitioned with petroleum ether 
to obtain a petroleum ether extract at a yield of 18.2 g. 
Chemicals
Alizarin red S, alcian blue 8GX, and paraformaldehyde 
were purchased from Sigma Chemicals (USA). Potassium 
hydroxide and glycerol were obtained from Merck (India). 
Animals
Twelve 3-month-old female Wistar rats weighing 
approximately 225 g were housed in the Central Animal 
Research Facility of Manipal University. The rats were 
housed in sanitized polypropylene cages containing sterile 
paddy husk as bedding. The animals were maintained 
under controlled conditions at a temperature of 23 ± 2 °C, 
humidity of 50 ± 5%, and a 12-h light– dark cycle. All 
animals were allowed free access to water and fed on a 
commercial diet. All of the conducted studies were approved 
by the Institutional Animal Ethical Committee (No.IAEC/
KMC/06/2006-2007), Kasturba Medical College, Manipal, 
according to the prescribed guidelines of the Committee for 
the Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA), according to prescribed guidelines of 
the Government of India. 
In order to impregnate the test rats and obtain a known 
gestational day, female rats in an estrous cycle were mated 
with young healthy male rats and subjected to a vaginal 
smear test after 12 hours. Detection of sperm in the vaginal 
smear was considered day 0 of pregnancy. 
Acute toxicity study
Acute toxicity was measured on fasting rats. Animals 
were divided into groups of 10 each and orally given 500, 
1000, 1500, 2500, 3000, 3500, 4000, 4500, and 5000 mg/kg 
body weight of CQ. The rats were continuously observed 
for 2 hours, checked regularly at one hour interval up to 6 
hours, and daily thereafter for 30 days. Mortality, if any, was 
recorded.27 
Experimental protocol
Pregnant rats were divided into control and CQ-treated 
groups (n=6 in each group). Pregnant rats in the treated 
group were treated with CQ petroleum ether extract of 500 
mg/kg/day from gestation day 9 until delivery. The control 
group received an equal volume of saline. 
At the end of the experiment, i.e., the day of birth, all the 
pups born to control and treated mothers were collected. 
Under anesthesia, the skin, viscera, and adipose tissue 
were carefully removed from the newborn pups. All the 
eviscerated pups were fixed in 95% ethanol for 5 days and 
then processed for alizarin red S - alcian blue double staining 
to view the entire skeleton.28 817
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Measurement of ossified skeleton (bone) and total skel-
eton length 
The alizarin red- alcian blue-stained limbs were 
photographed with scales to measure the ossified skeleton 
length and the total lengths of the forelimb and hindlimb 
bones. The length of the ossified skeleton (bone) was 
measured using Scion image software for Windows (NIH 
software). The software was calibrated and the length was 
measured as a grey scale image (BMP) of the original JPEG 
image. The lengths of the humerus, radius, ulna, femur, tibia, 
and fibula were measured (n=6 limbs in each group), and the 
percentages of the total lengths of the mineralized skeletons 
in the control and treated groups were calculated. 
Statistical analysis: 
Data are expressed as mean ± SEM (standard errors of 
mean). Data were analyzed by Student’s t-test. Probability 
(P) values less than 0.05 were considered significant. 
RESULTS 
The oral administration of Cissus quadrangularis plant 
petroleum ether extract did not cause mortality or any signs 
of clinical abnormality in the treated pregnant rats. 
The Scion image data revealed a significant difference 
in the extent of ossification of the bones of the treated group 
compared to the control group. 
The effect of CQ petroleum ether extract on the ossifi-
cation of the humerus
The scion image data concerning the length of ossified 
skeleton revealed a significant difference in the extent of 
ossification of the humerus in treated compared to control 
pups. The mean length of the ossified humerus in the control 
pups was 3.97 ± 0.06 mm (n=6; 64.97 ± 1.09% of total 
length of the humerus), while the mean length of the ossified 
humerus in pups born to CQ-treated mothers was 4.36 ± 
0.04 mm (n=6;73.84 ± 0.89% of total length of the humerus 
(P<0.0001, Student’s t-test; Figures 1 and 2).
Effect of the CQ extract on the ossification of the radius 
and ulna
The lengths of the ossified radius and ulna were found 
to be 3.58 ± 0.02 mm (n=6; 66.73 ± 1.09% of total length) 
and 4.42 ± 0.03 mm (n=6; 74.16 ± 0.61% of total length), 
respectively, in the control pups. The lengths of the ossified 
radius and ulna of pups born to treated mothers were found 
to be significantly increased compared to the control pups 
(Radius: 3.64 ± 0.04 mm, n=6; 72.49 ± 0.79% of total 
length (P<0.001); Ulna: 4.68 ± 0.05 mm, n=6; 79.14 ± 
0.97% of total length (P<0.001, Student’s t-test; Figures 
1 and 2). 
The effect of the CQ extract on the ossification of the 
femur
The length of the ossified femur was 3.06 ± 0.02 mm 
(n=6; 52.52 ± 0.35% of total length) in the control pups and 
3.66 ± 0.04 mm in pups born to CQ-treated mothers (n=6; 
Figure 1 - Percentages of total lengths of humerus, radius, and ulna ossified 
in pups born to control and treated (petroleum ether extract of CQ, 500 mg/
kg/day) mothers. Note that there are significant increases in the lengths of 
the ossified humerus, (**** P<0.0001, Student’s t-test), radius, and ulna (*** 
P<0.001 Student’s t-test) in pups born to CQ-treated mothers
Figure 2 - Photograph of Alizarin red S and alcian blue-stained forelimbs 
showing the ossified and unossified portions of bones in pups born to control 
or CQ petroleum ether extract-treated mothers. Note the increased lengths 
of the humerus, radius, and ulna in the treated group. Scale bar = 1 cm in 
both photographs818
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70.85 ± 0.70% of total length, P<0.0001 Student’s t-test, 
Figures 3 and 4). 
The effect of the extract on the ossification of the tibia 
and fibula
The lengths of the ossified tibia and fibula were 3.77 ± 
0.14 mm (n=6; 64.97 ± 1.17% of total length) and 3.41 ± 0.04 
mm (n=6; 65.34 ± 1.41% of total length), respectively, in the 
control group. The lengths of the ossified tibia and fibula of in 
pups born to the treated mothers were found to be significantly 
increased compared to control pups (Tibia: 4.17 ± 0.07 mm, 
n=6; 75.77 ± 1.52% of total length (P<0.0001, Student’s 
t-test); Fibula: 4.12 ± 0.05 mm, n=6; 80.55 ± 1.21% of total 
length (P<0.0001, Student’s t- test; Figures 3 and 4). 
DISCUSSION
This study evaluates the effect of CQ petroleum ether 
extract on the ossification of the fetal skeleton. Pups born 
to mothers treated with 500 mg/kg of CQ from gestation 
day 9 until delivery exhibited a significant increase in the 
lengths of the ossified parts of the skeleton in both forelimbs 
and hindlimbs. This study is an extension of our previous 
investigations on the effect of CQ extract on the development 
of the fetal skeleton in rats. In that study, we reported that 
the treatment of pregnant rats with a CQ ethanolic extract 
of 750 mg/kg/day enhanced the ossification of the fetal 
skeleton.18 The present study demonstrates, for the first 
time, that maternal treatment with petroleum ether extracts 
during gestation can dramatically influence the skeleton of 
the fetus. 
In the present study, CQ was used at a dose of 500 mg/
kg body weight based on our acute toxicity studies. This 
dose appears to be safe, as treated animals did not show any 
adverse effects; however, a dose-response study is essential 
to determining the minimum effective dose that shows a 
maximum effect. 
The increased mineralization (ossification) observed 
in the present study could be attributed to the phytogenic 
steroid compounds isolated from this plant, which may have 
altered the maternal estrogen levels or reached the growing 
fetus through the placenta.15 Singh et. al.12 have reported the 
presence of several phytosteroids in the extract of CQ. It 
has been reported that such phytosteroids can pass through 
the placental barrier.30,31 This was observed in the study 
by Magliaccio et al.,31 wherein they altered the maternal 
estrogen levels by providing external steroidal hormones, 
and demonstrated alterations in the skeletons of neonatal 
pups. The bone growth observed in pups born to treated 
mothers in the present study may be due to proliferation and 
differentiation of chondrocytes. This may be regulated by 
phytogenic steroids probably present in the CQ petroleum 
ether extract, which may act as an analog of estrogen. It 
has been reported that estrogen stimulates proliferation and 
differentiation of the chondrocytes and thereby increases 
bone length.32
Animal experiments have demonstrated that hormones 
affect development during sensitive periods of early life 
and permanently program the structure and physiology of 
the bone tissues.33 It is well known that changes in estrogen 
levels can dramatically modify bone tissue turnover in both 
postmenopausal women34 and ovarectomized animals.35 In 
addition, long term exposure of adult animals to estradiol or 
diethylstilbestrol induces hyperplasia of bone tissue.22
These data strongly suggest that bone tissue directly 
responds to estrogen-like target tissues. 
Figure 3 - Percentages of total lengths of femur, tibia, and fibula ossified in 
pups born to control or CQ petroleum ether extract-treated mothers. Note 
there is a significant increase in the lengths of the ossified femur, tibia, and 
fibula (**** P<0.0001, Student’s t-test)
Figure 4 - Photograph of Alizarin red S and alcian blue-stained pup hindlimbs 
showing the ossified and unossified portions of bones in pups born to control 
or CQ petroleum ether extract-treated mothers. Note the increased lengths 
of the femur, tibia, and fibula in the treated group. Scale bar = 1cm in both 
photographs819
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Further, transient neonatal exposure of female mice 
to estrogen has been shown to increase the bone mass in 
the animals during adulthood.26 Thus, these data strongly 
suggest that alterations of estrogen levels before puberty, 
especially in early phases of development, can dramatically 
influence skeletal maturation, including final peak bone 
density. Perturbation in the maternal estrogen level during 
pregnancy has been shown to alter the developing skeleton.31 
Evidence indicates that osteoporosis can be triggered during 
the intrauterine growth period and can result in a defective 
skeleton for newborn offspring.33 In these cases, treatment 
with a petroleum ether extract may be useful in reversing/
preventing the osteoporotic fractures and improving the bone 
mineral density. 
In conclusion, the results of the present study provide 
evidence that CQ petroleum ether extract is a promising agent 
for treating intrauterine growth defects in the skeletal system. 
Further studies on the isolation and characterization of the 
active chemical constituents of CQ petroleum ether extract 
that are responsible for bone anabolic activity are warranted; 
however, further basic studies and clinical trials will be needed 
to substantiate the efficacy of Cissus quadrangularis. 
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